Company Information

Corporate Profile
Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Our highly trained group of hematopathologists utilizes sophisticated diagnostic technologies to provide a differentiated, specialized and integrated assessment of a patient’s condition, aiding physicians in making vital decisions concerning the treatment of malignancies of the blood and bone marrow, and other forms of cancer.


Recent NewsMore >>
DateTitle 
02/04/10Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results
CARLSBAD, Calif., Feb 04, 2010 /PRNewswire via COMTEX/ -- Genoptix, Inc. (Nasdaq: GXDX), a provider of personalized diagnostic services, announced today that it expects to report its financial results for the fourth quarter and full-year 2009 after closing of the NASDAQ Global Select Market on Thursday, February 25, 2010. A conference call hosted by President and CEO, Tina S. Nova, Ph.D., and other members of senior management will take place on the same day at 2:00pm PST (5:00pm EST) and will... 
Printer Friendly Version
01/19/10Genoptix Announces Participation at Jefferies 2010 Global Healthcare Services Conference
CARLSBAD, Calif., Jan 19, 2010 /PRNewswire via COMTEX/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the Jefferies 2010 Global Healthcare Services Conference in New York City on January 25-27, 2010. Doug Schuling, EVP and CFO of Genoptix, will present at the conference on Monday, January 25, 2010 beginning at approximately 4:00 p.m. EST, when he will provide an overview of the Company's specialized diagnostic labora... 
Printer Friendly Version
01/04/10Genoptix Announces Participation at 28th Annual J.P. Morgan Healthcare Conference
CARLSBAD, Calif., Jan 04, 2010 /PRNewswire-FirstCall via COMTEX/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the 28th Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco, Calif. on January 11-14, 2010. Dr. Tina S. Nova, President and CEO of Genoptix, and Sam Riccitelli, Genoptix's EVP and COO, will present at the conference on Monday, January 11, 2010 beginning at a... 
Printer Friendly Version



Upcoming EventsMore >>
Webcast ImageWebcast
Q4 2009 GENOPTIX INC Earnings Conference Call (Live)
02/25/10 at 5:00 p.m. ET
Q4 2009 GENOPTIX INC Earnings Conference Call
Thursday, February 25, 2010 5:00 p.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Stock Quote
GXDX (Common Stock)
Price$31.25
Volume230,152
Open$32.40
Previous Close$32.39
Change (%) Stock is Down 1.14 (3.52%)
ExchangeNASDAQ
Data as of 02/08/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Contact
Contact Investor Relations:
Marcy Graham
Sr. Director, Investor Relations
Genoptix, Inc.
2110 Rutherford Road
Carlsbad, CA 92008
800-881-3100
investorrelations@genoptix.com

E-mail Alerts
Enter your e-mail address here:

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.